This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

PharmChem (PCHM) Stock Overview

Provides PharmChek Sweat Patch that is used to detect drugs of abuse. More details

PCHM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	2/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($17M)

PCHM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

PharmChem, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for PharmChem
Historical stock prices
Current Share Price	US$3.75
52 Week High	US$3.98
52 Week Low	US$2.95
Beta	0
1 Month Change	1.63%
3 Month Change	5.84%
1 Year Change	4.17%
3 Year Change	33.93%
5 Year Change	11.94%
Change since IPO	-60.00%

Recent updates

Shareholder Returns

	PCHM	US Medical Equipment	US Market
7D	1.4%	0.1%	3.4%
1Y	4.2%	-8.5%	28.4%

Return vs Industry: PCHM matched the US Medical Equipment industry which returned 4.6% over the past year.

Return vs Market: PCHM underperformed the US Market which returned 17.5% over the past year.

Price Volatility

Is PCHM's price volatile compared to industry and market?
PCHM volatility
PCHM Average Weekly Movement	7.1%
Medical Equipment Industry Average Movement	7.9%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.0%
10% least volatile stocks in US Market	3.3%

Stable Share Price: PCHM has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PCHM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2000	n/a	Thompson Clark	www.pharmchek.com

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.

PharmChem, Inc. Fundamentals Summary

How do PharmChem's earnings and revenue compare to its market cap?
PCHM fundamental statistics
Market cap	US$17.38m
Earnings (TTM)	-US$2.04m
Revenue (TTM)	US$25.73m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PCHM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PCHM income statement (TTM)
Revenue	US$25.73m
Cost of Revenue	US$19.98m
Gross Profit	US$5.74m
Other Expenses	US$7.78m
Earnings	-US$2.04m

Last Reported Earnings

Mar 31, 2004

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did PCHM perform over the long term?

See historical performance and comparison

Dividends

6.7%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/08/28 17:07
End of Day Share Price	2025/08/28 00:00
Earnings	2004/03/31
Annual Earnings	2003/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PharmChem, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

PharmChem, Inc.OTCPK:PCHM Stock Report